The overexpression of GPX4 in ALS mouse models exhibits reduced systemic cytotoxicity of SOD1, late delayed disease-onset, improved motor function, and longer survival, which are associated with faster recovery from spinal motor neuron injury and repressed lipid peroxidation (Chen X. et al., 2021). Here, GPX4 is linked to amyotrophic lateral sclerosis.